Marike L. D. Broekman

ORCID: 0000-0002-0226-0119
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Glioma Diagnosis and Treatment
  • Meningioma and schwannoma management
  • Brain Metastases and Treatment
  • Extracellular vesicles in disease
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Lung Cancer Research Studies
  • Radiomics and Machine Learning in Medical Imaging
  • Biomedical Ethics and Regulation
  • Pituitary Gland Disorders and Treatments
  • History of Medical Practice
  • MicroRNA in disease regulation
  • Ethics in Clinical Research
  • Surgical Simulation and Training
  • Head and Neck Surgical Oncology
  • Palliative Care and End-of-Life Issues
  • Immune cells in cancer
  • Artificial Intelligence in Healthcare and Education
  • Anatomy and Medical Technology
  • RNA Interference and Gene Delivery
  • Management of metastatic bone disease
  • Cardiac, Anesthesia and Surgical Outcomes
  • Virus-based gene therapy research
  • Nanoplatforms for cancer theranostics
  • Neurosurgical Procedures and Complications
  • Diversity and Career in Medicine

Medisch Centrum Haaglanden
2016-2025

Leiden University Medical Center
2016-2025

Harvard University
2010-2025

Massachusetts General Hospital
2016-2025

Oncode Institute
2024

Brigham and Women's Hospital
2016-2023

Harvard NeuroDiscovery Center
2019-2023

Leiden University
2018-2023

University Medical Center Utrecht
2011-2022

Parnassia Groep
2022

Clotilde Théry Kenneth W. Witwer Elena Aïkawa María José Alcaraz Johnathon D. Anderson and 95 more Ramaroson Andriantsitohaina Anna Antoniou Tanina Arab Fabienne Archer Georgia K. Atkin‐Smith D. Craig Ayre Jean‐Marie Bach Daniel Bachurski Hossein Baharvand Leonora Balaj Shawn Baldacchino Natalie Bauer Amy A. Baxter Mary Bebawy Carla Beckham Apolonija Bedina Zavec Abderrahim Benmoussa Anna C. Berardi Paolo Bergese Ewa Bielska Cherie Blenkiron Sylwia Bobis‐Wozowicz Éric Boilard Wilfrid Boireau Antonella Bongiovanni Francesc E. Borràs Steffi Bösch Chantal M. Boulanger Xandra O. Breakefield Andrew Breglio Meadhbh Á. Brennan David R. Brigstock Alain Brisson Marike L. D. Broekman Jacqueline Bromberg Paulina Bryl‐Górecka Shilpa Buch Amy H. Buck Dylan Burger Sara Busatto Dominik Buschmann Benedetta Bussolati Edit I. Buzás James Brian Byrd Giovanni Camussi David R. F. Carter Sarah Caruso Lawrence W. Chamley Yu‐Ting Chang Chih‐Chen Chen Daiwen Chen Lesley Cheng Andrew R. Chin Aled Clayton Stefano Piatto Clerici Alex Cocks Emanuele Cocucci Robert J. Coffey Anabela Cordeiro‐da‐Silva Yvonne Couch Frank A. W. Coumans Beth Coyle Rossella Crescitelli Miriã Ferreira Criado Crislyn D’Souza‐Schorey Saumya Das Amrita Datta Chaudhuri Paola de Candia Eliezer F De Santana Olivier De Wever Hernando A. del Portillo Tanguy Demaret Sarah Deville Andrew Devitt Bert Dhondt Dolores Di Vizio Lothar C. Dieterich Vincenza Dolo Ana Paula Domínguez Rubio Massimo Dominici Maurício Rocha Dourado Tom A. P. Driedonks Filipe V. Duarte Heather M. Duncan Ramon M. Eichenberger Karin M. Ekström Samir EL Andaloussi Céline Élie-Caille Uta Erdbrügger Juan Manuel Falcón‐Pérez Farah Fatima Jason E. Fish Miguel Flores‐Bellver András Försönits Annie Frelet‐Barrand

ABSTRACT The last decade has seen a sharp increase in the number of scientific publications describing physiological and pathological functions extracellular vesicles (EVs), collective term covering various subtypes cell‐released, membranous structures, called exosomes, microvesicles, microparticles, ectosomes, oncosomes, apoptotic bodies, many other names. However, specific issues arise when working with these entities, whose size amount often make them difficult to obtain as relatively...

10.1080/20013078.2018.1535750 article EN cc-by-nc Journal of Extracellular Vesicles 2018-11-23

Nano-sized extracelullar vesicles (EVs) released by various cell types play important roles in a plethora of (patho)physiological processes and are increasingly recognized as biomarkers for disease. In addition, engineered EV EV-inspired liposomes hold great potential drug delivery systems. Major technologies developed high-throughput analysis individual include nanoparticle tracking (NTA), tunable resistive pulse sensing (tRPS) high-resolution flow cytometry (hFC). Currently, there is need...

10.1016/j.jconrel.2014.12.041 article EN cc-by-nc-nd Journal of Controlled Release 2014-12-30

Glioblastoma multiforme (GBM) is the most common primary brain tumor and without exception lethal. GBMs modify immune system, which contributes to aggressive nature of disease. Particularly, cells monocytic lineage, including monocytes, macrophages microglia, are affected. We investigated influence GBM-derived extracellular vesicles (EVs) on phenotype cells. Proteomic profiling showed GBM EVs be enriched with proteins functioning in matrix interaction leukocyte migration. appeared skew...

10.1002/ijc.29521 article EN International Journal of Cancer 2015-03-20

Background Understanding the pathogenic role of extracellular vesicles (EVs) in disease and their potential diagnostic therapeutic utility is extremely reliant on in‐depth quantification, measurement identification EV sub‐populations. Quantification EVs has presented several challenges, predominantly due to small size such as exosomes availability various technologies measure nanosized particles, each technology having its own limitations. Materials Methods A standardized methodology...

10.3402/jev.v5.31242 article EN cc-by-nc Journal of Extracellular Vesicles 2016-01-01

Gliomas are primary, diffusely infiltrating brain tumors. Microglia innate immune cells in the CNS and make up a substantial portion of tumor mass. Glioma shape their microenvironment, communicating with reprogramming surrounding cells, resulting enhanced angiogenesis, suppression, remodeling extracellular matrix. communicate microglia, part by releasing vesicles (EVs). Mouse glioma stably expressing palmitoylated GFP to label EVs were implanted intracranially into syngeneic miR-21-null...

10.1016/j.celrep.2019.08.036 article EN cc-by-nc-nd Cell Reports 2019-09-01

Background: Cells secrete different types of membrane vesicles (MVs), which may act as important entities in normal human physiology and various pathological processes. The established methods for quantification MVs require purification or preanalytical handling samples with labeling moieties. Aim: authors' aim was to develop a method high-throughput, labeling-free nonpurified MVs. Materials & methods: Scanning ion occlusion sensing technology, relies on the detection particles upon their...

10.2217/nnm.12.173 article EN Nanomedicine 2013-02-05

Abstract BACKGROUND Although survival statistics in patients with glioblastoma multiforme (GBM) are well-defined at the group level, predicting individual patient remains challenging because of significant variation within strata. OBJECTIVE To compare statistical and machine learning algorithms their ability to predict GBM deploy best performing model as an online calculator. METHODS Patients undergoing operation for a histopathologically confirmed were extracted from Surveillance...

10.1093/neuros/nyz403 article EN cc-by-nc-nd Neurosurgery 2019-09-10

Epileptogenic glioblastomas are thought to convey a favorable prognosis, either due early diagnosis or potential antitumor effects of antiepileptic drugs. We investigated the relationship between survival and epilepsy at presentation, diagnosis, drug therapy in glioblastoma patients. Multivariable Cox regression was applied data 647 consecutive patients diagnosed with de novo 2005 2013 order investigate association In addition, we quantified valproic acid (VPA) treatment. Epilepsy correlated...

10.1093/neuonc/nov238 article EN Neuro-Oncology 2015-09-29

Abstract Background Breast cancer (BC) brain metastases (BM) can have discordant hormonal or human epidermal growth factor receptor 2 (HER2) expression compared with corresponding primary tumors. This study aimed to describe incidence, predictors, and survival outcomes of receptors associated subtype switching in BM. Methods BCBM patients seen at 4 tertiary institutions who had undergone BM resection biopsy were included. Surgical pathology reports retrospectively assessed determine...

10.1093/neuonc/noaa013 article EN cc-by-nc Neuro-Oncology 2020-01-21

Glioblastomas are the most common and lethal primary brain tumors. Microglia, resident immune cells of brain, survey their environment respond to pathogens, toxins, Glioblastoma communicate with microglia, in part by releasing extracellular vesicles (EVs). Despite presence large numbers microglia glioblastoma, tumors continue grow, these neuroimmune appear incapable keeping tumor check. To understand this process, we analyzed gene expression interacting glioblastoma cells.We used RNASeq...

10.1186/s12974-020-01797-2 article EN cc-by Journal of Neuroinflammation 2020-04-16

OBJECTIVE If not anticipated and prearranged, hospital stay can be prolonged while the patient awaits placement in a rehabilitation unit or skilled nursing facility following elective spine surgery. Preoperative prediction of likelihood postoperative discharge to any setting other than home (i.e., nonroutine discharge) after inpatient surgery would helpful terms decreasing length stay. The purpose this study was use machine learning algorithms develop an open-access web application for...

10.3171/2018.8.focus18340 article EN Neurosurgical FOCUS 2018-11-01
Coming Soon ...